Cripto Antibodies

Santa Cruz Biotechnology features a diverse variety of Cripto monoclonal antibodies for research focused on understanding Cripto's role in cellular processes. Cripto Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cripto, a member of the EGF-CFC family, plays a critical role in embryonic development and cell signaling. Research has shown that Cripto influences stem cell maintenance and differentiation, making it a significant target for studies related to cancer and developmental biology. Understanding Cripto's function can provide insights into various pathological conditions, including tumorigenesis and tissue regeneration. Researchers investigating Cripto's involvement in cell signaling pathways can utilize specific monoclonal antibodies to detect and analyze expression patterns in different tissues and cell types. Advanced research techniques supported by monoclonal antibodies enable detailed examination of Cripto's molecular interactions and regulatory mechanisms. Investigating Cripto's role in development and disease progression helps expand knowledge of cellular processes and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for Cripto research contribute to advancing scientific understanding of developmental biology and cancer research.